Delivery Order HHSN272201100009I-HHSN27200004
Award Date
9/30/15
Potential Completion Date
9/29/16
Potential Value
$747K
Federal Agency
NIAID DEA OA Acquisitions
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $638,080 contract is for in vitro assessment of antimicrobial activity, under the In Vitro Antimicrobial Assessments 2011-2018 master IDIQ contract. The period of performance is from November 4, 2016 to October 31, 2017. AAHI is a prime contractor experienced in...
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute. The $4,140 contract is for infectious disease research functions and does not have a set-aside designation. AAHI, which also operates under the names Aahi, Idri, and Infectious Disease Research Institute, conducts research and...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS), to Access To Advanced Health Institute (AAHI), doing business as Aahi, Idri, and Infectious Disease Research Institute. The $2,980 contract is for infectious disease research and development, specifically related to vaccine adjuvants. AAHI is a non-profit biotech research institute that combines academic...
This is a federal contract award to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract, titled "PANACEA", is a non-set-aside Other Transaction Agreement with a ceiling value of $2,854,631.10 and an ultimate completion date of August 29, 2024. AAHI, doing business as Aahi, Idri, and Infectious Disease Research Institute, is a prime contractor experienced in conducting research and development of vaccine...
This is a $18,576,013.05 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute located in Seattle, Washington. The contract is for the development of vaccine candidates for biodefense, antimicrobial resistant infections, and emerging infectious diseases, under NIAID's Broad Agency Announcement (BAA) Research Area 001. AAHI...
This federal contract award, valued at $16,731,358.00, was made by the National Institute of Allergy and Infectious Diseases (NIAID) to the Access To Advanced Health Institute (AAHI), a non-profit biotech research institute. The contract is for the continued development of vaccine candidates for biodefense, antimicrobial resistance, emerging infectious diseases, and respiratory pathogens. No set-aside designation was used. AAHI has subcontracted with several institutions, including Emory...
This is a Firm Fixed Price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The contract is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and has a ceiling value of $27,108. It is not a set-aside contract. The contract was awarded as a task order under NIAID's "In Vitro Antimicrobial Assessments...
This firm fixed-price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit research organization. The contract, valued at $26,480.00, is for "IN VITRO ASSESSMENTS FOR ANTIMICROBIAL ACTIVITY" and was awarded under the "In Vitro Antimicrobial Assessments 2011-2018" indefinite delivery/indefinite...
This contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the Southern Research Institute, a corporate entity tax-exempt non-profit organization. The contract is a Delivery Order under the In Vitro Assessments of Antimicrobial Activity (IVAAA) Indefinite Delivery/Indefinite Quantity (ID/IQ) contract vehicle. The $1,275,123.00 cost-plus-fixed-fee contract is for evaluating therapeutic product...